Protein acrobatics in pairs--dimerization via domain swapping.

Ever since Anfinsen’s seminal experiments about 50 years ago, it is widely accepted that the amino acid sequence of a protein determines its unique three-dimensional structure. While generally true for single chain proteins, in multimers, two or more individual chains can be assembled in different ways. Therefore, making a distinction between tertiary and quaternary protein structure may be prudent when evoking Anfinsen’s postulate. The folded, native structure of a protein is considered the lowest energy state, with folding being driven by a combination of entropic and enthalpic forces that result in the burial of hydrophobic residues and a specific distribution of polar residues mainly on the surface. This balanced interplay of forces creates a network of defined attractive and repulsive forces that arrange the chain in well-defined, secondary structure elements. The predominance of such cooperative folding on smooth, free energy landscapes for most small, naturally occurring single chain proteins has been explained as the product of natural selection acting at the level of an individual amino acid sequence. When initially established, the protein structure database [1] primarily contained single chain, monomeric proteins; however, over the past several years, the number of multimeric proteins represented in the PDB has increased rapidly and continues to grow. Indeed, multimeric proteins are prevalent in all organisms, and oligomerization is generally believed to be favored during protein evolution [2], since multimers are endowed with structural and functional advantages, such as improved stability and control over the accessibility and specificity of active sites. For multimers, the specification of a unique oligomeric state may not always be unambiguous. Often small changes in protein composition or environment can tip the balance from one arrangement to the next, with some proteins coexisting in more than one oligomeric state. A classic example of alternate oligomers is the Bence-Jones protein, characterized by X-ray diffraction more than 40 years ago. This protein exists in three quaternary structures [3] that vary in their domain interactions. Alternate quaternary assemblies of functionally distinct homo-oligomeric proteins have recently been termed ‘morpheeins’ [4], with the enzyme porphobilinogen synthase (PBGS) as the prototypical example. PBGS exists in an equilibrium between an octamer, a hexamer, and two dimer conformations [5] A special case of oligomer assembly occurs via domain swapping. The term three-dimensional (3D) domain-swapping, or simply domain swapping, was coined by Eisenberg [6] for an oligomerization mechanism in which two or more polypeptide chains exchange identical units. The exchanged portion may consist of a single secondary structure element or an entire globular domain. If exchange is reciprocal between two monomers, dimers are formed, or, if more chains are involved, oligomers ensue (Figure 1). Figure 1 Schematic representation of features inherent to domain swapped structures. Not surprisingly, most domain-swapped structures have been determined by X-ray crystallography. Currently, more than 60 examples of domain swapped structures are available in the PDB [1]. According to the original definition, both monomeric and oligomeric structures must be observed for an identical protein [7], with both states found either in crystals or one in a crystal and the other in solution. This purist’s designation, however, has been relaxed over the last decade. Structures are called domain swapped, even if no structure of the closed monomer has ever been observed or where only a homolog exhibits a closed monomer. Originally, in the former case, the protein is a ‘candidate’ for domain swapping, while in the latter, the oligomers are classified as ‘quasi-domain-swapped’. In the present review, ‘quasi-domain-swapped’ structures are termed domain swapped when the amino acid sequences of monomer and multimer are very similar, i.e. the proteins are mutants or close homologs. The collection of domain swapped protein structures described up to 2002 has been summarized in reviews by Newcomer [8] and Liu and Eisenberg [7]. A more recent review focuses on proteins that display 3D domain swapping as well as fibril formation and discusses the possible involvement of domain swapping in protein deposition diseases [9]. Therefore, I only briefly summarized notations and terminology and the reader is referred to the above reviews for more in depth descriptions of the basic features of domain swapping.

[1]  Angela M Gronenborn,et al.  A captured folding intermediate involved in dimerization and domain-swapping of GB1. , 2004, Journal of molecular biology.

[2]  Elena Matei,et al.  Solution and crystal structures of a sugar binding site mutant of cyanovirin-N: no evidence of domain swapping. , 2008, Structure.

[3]  Anchi Cheng,et al.  Structure of Full-Length HIV-1 CA: A Model for the Mature Capsid Lattice , 2007, Cell.

[4]  G. Wagner,et al.  Domain-swapped dimerization of the HIV-1 capsid C-terminal domain , 2007, Proceedings of the National Academy of Sciences.

[5]  Angela M Gronenborn,et al.  A protein contortionist: core mutations of GB1 that induce dimerization and domain swapping. , 2003, Journal of molecular biology.

[6]  W. Sundquist,et al.  Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. , 1997, Science.

[7]  A. Gronenborn,et al.  Solution structure of cyanovirin-N, a potent HIV-inactivating protein , 1998, Nature Structural Biology.

[8]  D. Eisenberg,et al.  Domain swapping: entangling alliances between proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Robert L Jernigan,et al.  Molecular mechanism of domain swapping in proteins: an analysis of slower motions. , 2004, Biophysical journal.

[10]  Fernanda L. Sirota,et al.  Mechanism and energy landscape of domain swapping in the B1 domain of protein G. , 2008, Journal of molecular biology.

[11]  W. Sundquist,et al.  Biological Crystallography Structures of the Hiv-1 Capsid Protein Dimerization Domain at 2.6 a Ê Resolution , 2022 .

[12]  G. Gotte,et al.  Oligomerization of Ribonuclease A , 2004, Journal of Biological Chemistry.

[13]  A D Cameron,et al.  All in the family: Structural and evolutionary relationships among three modular proteins with diverse functions and variable assembly , 1998, Protein science : a publication of the Protein Society.

[14]  Hans-Georg Kräusslich,et al.  The HIV-1 capsid protein C-terminal domain in complex with a virus assembly inhibitor , 2005, Nature Structural &Molecular Biology.

[15]  Mariella Tegoni,et al.  Domain swapping of a llama VHH domain builds a crystal‐wide β‐sheet structure , 2004 .

[16]  Witold K. Surewicz,et al.  Crystal structure of the human prion protein reveals a mechanism for oligomerization , 2002, Nature Structural Biology.

[17]  A. Gronenborn,et al.  The evolutionarily conserved family of cyanovirin-N homologs: structures and carbohydrate specificity. , 2008, Structure.

[18]  M. Bertoldi,et al.  Structural properties of trimers and tetramers of ribonuclease A , 2001, Protein science : a publication of the Protein Society.

[19]  D Eisenberg,et al.  The crystal structure of a 3D domain-swapped dimer of RNase A at a 2.1-A resolution. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Alexander Wlodawer,et al.  Structures of the Complexes of a Potent Anti-HIV Protein Cyanovirin-N and High Mannose Oligosaccharides* , 2002, The Journal of Biological Chemistry.

[21]  U. Baxa,et al.  The GB1 amyloid fibril: recruitment of the peripheral beta-strands of the domain swapped dimer into the polymeric interface. , 2005, Journal of molecular biology.

[22]  Angela M Gronenborn,et al.  The point mutation A34F causes dimerization of GB1 , 2007, Proteins.

[23]  D. Eisenberg,et al.  Design of three-dimensional domain-swapped dimers and fibrous oligomers. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Moore,et al.  On the aggregation of bovine pancreatic ribonuclease. , 1962, Archives of biochemistry and biophysics.

[25]  A. Gronenborn,et al.  A novel, highly stable fold of the immunoglobulin binding domain of streptococcal protein G. , 1993, Science.

[26]  C. Bewley,et al.  Engineering an obligate domain-swapped dimer of cyanovirin-N with enhanced anti-HIV activity. , 2002, Journal of the American Chemical Society.

[27]  S. Cusack,et al.  Head‐to‐tail dimers and interdomain flexibility revealed by the crystal structure of HIV‐1 capsid protein (p24) complexed with a monoclonal antibody Fab , 1999, The EMBO journal.

[28]  Wei Li,et al.  Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization , 2008, Nature.

[29]  Ping Zhu,et al.  Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition , 2003, Science.

[30]  K Wüthrich,et al.  NMR solution structure of the human prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Alexander Wlodawer,et al.  Domain-Swapped Structure of the Potent Antiviral Protein Griffithsin and Its Mode of Carbohydrate Binding , 2006, Structure.

[32]  J. Matthews,et al.  The power of two: protein dimerization in biology. , 2004, Trends in biochemical sciences.

[33]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[34]  M. Schiffer,et al.  Three quaternary structures for a single protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Samuel S. Cho,et al.  Domain swapping is a consequence of minimal frustration. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[36]  G. Wagner,et al.  Mammalian SCAN domain dimer is a domain-swapped homolog of the HIV capsid C-terminal domain. , 2005, Molecular cell.

[37]  J. Onuchic,et al.  Fast-folding experiments and the topography of protein folding energy landscapes. , 1996, Chemistry & biology.

[38]  A. Gronenborn,et al.  Core mutations switch monomeric protein GB1 into an intertwined tetramer , 2002, Nature Structural Biology.

[39]  E. Jaffe Morpheeins--a new structural paradigm for allosteric regulation. , 2005, Trends in biochemical sciences.

[40]  M. Newcomer,et al.  Protein folding and three-dimensional domain swapping: astrained relationship? , 2002 .

[41]  A. Gronenborn,et al.  Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping. , 1999, Journal of molecular biology.

[42]  David Eisenberg,et al.  Deposition diseases and 3D domain swapping. , 2006, Structure.

[43]  Valerie Daggett,et al.  Insight into ribonuclease A domain swapping by molecular dynamics unfolding simulations. , 2005, Biochemistry.

[44]  Peter G Wolynes,et al.  Overcoming residual frustration in domain-swapping: the roles of disulfide bonds in dimerization and aggregation , 2005, Physical biology.

[45]  D. Eisenberg,et al.  Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation process , 2003, Nature Structural Biology.

[46]  Lei Tang,et al.  Shape shifting leads to small-molecule allosteric drug discovery. , 2008, Chemistry & biology.

[47]  David Eisenberg,et al.  3D domain swapping: As domains continue to swap , 2002, Protein science : a publication of the Protein Society.

[48]  David Eisenberg,et al.  A domain-swapped RNase A dimer with implications for amyloid formation , 2001, Nature Structural Biology.

[49]  D. Eisenberg,et al.  Structures of the two 3D domain‐swapped RNase A trimers , 2002, Protein science : a publication of the Protein Society.

[50]  D Baker,et al.  Single-site mutations induce 3D domain swapping in the B1 domain of protein L from Peptostreptococcus magnus. , 2001, Structure.

[51]  L. Itzhaki,et al.  Three-dimensional domain swapping in p13suc1 occurs in the unfolded state and is controlled by conserved proline residues , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[52]  M. Perutz,et al.  Crystal structure of a dimeric chymotrypsin inhibitor 2 mutant containing an inserted glutamine repeat. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Alexander Wlodawer,et al.  The domain-swapped dimer of cyanovirin-N is in a metastable folded state: reconciliation of X-ray and NMR structures. , 2002, Structure.